Disclosures

Disclosures

The Association of the British Pharmaceutical Industry (ABPI) Code of Practice requires all companies to document and publicly disclose certain transfers of value (ToVs) made directly or indirectly to healthcare professionals (HCPs), other relevant decision makers (ORDMs) and healthcare organisations (HCOs) located in Europe, as well as to research & development (R&D) projects and patient organisations.

Working with HCPs/ORDMs and HCOs

Merz is committed to compliance and working within the ABPI Code of Practice and applicable laws. For payments made to HCPs/ORDMs and HCOs, including R&D projects in the last three years (2016, 2017 and 2018), please refer to the ABPI Disclosure Database:

Disclosure Database

Working with patient groups

Merz have also made the following contributions to working with patient groups in 2016, 2017 and 2018:

Contributions to Patient Organisations in 2016

Organisation

Amount

Description

The Stroke Association

£3607.00

Contribution to cost of event

Contributions to Patient Organisations in 2017

Organisation

Amount

Description

The Stroke Association

£4000

Contribution towards the cost of producing stroke guides for patients

Action for Dystonia, Diagnosis, Education and Research (ADDER)

£760

Funding support for patient leaflets

Chest Heart & Stroke Scotland

£500

Contribution towards the cost of a meeting.

UK National Intrathecal Baclofen Trust

£500

Contribution towards the cost of a meeting

Contributions to Patient Organisations in 2018

Organisation

Amount

Description

The Dystonia Society

£500

Contribution towards the cost of a meeting.

The Stroke Association

£4180

Contribution towards the cost of the UK Stroke Forum Conference 2018. In return Merz UK received stand space at the event.

The Stroke Association

£1250

Contribution towards the cost of the Northern Ireland Stroke Conference 2018.  In return Merz UK received stand space at the event.